National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH), Bethesda, MD 20892, USA.
J Bone Miner Res. 2013 Feb;28(2):271-82. doi: 10.1002/jbmr.1767.
Tissue-nonspecific alkaline phosphatase (TNAP) is expressed in mineralizing tissues and functions to reduce pyrophosphate (PP(i) ), a potent inhibitor of mineralization. Loss of TNAP function causes hypophosphatasia (HPP), a heritable disorder marked by increased PP(i) , resulting in rickets and osteomalacia. Tooth root cementum defects are well described in both HPP patients and in Alpl(-/-) mice, a model for infantile HPP. In Alpl(-/-) mice, dentin mineralization is specifically delayed in the root; however, reports from human HPP patients are variable and inconsistent regarding dentin defects. In the current study, we aimed to define the molecular basis for changes in dentinogenesis observed in Alpl(-/-) mice. TNAP was found to be highly expressed by mature odontoblasts, and Alpl(-/-) molar and incisor roots featured defective dentin mineralization, ranging from a mild delay to severely disturbed root dentinogenesis. Lack of mantle dentin mineralization was associated with disordered and dysmorphic odontoblasts having disrupted expression of marker genes osteocalcin and dentin sialophosphoprotein. The formation of, initiation of mineralization within, and rupture of matrix vesicles in Alpl(-/-) dentin matrix was not affected. Osteopontin (OPN), an inhibitor of mineralization that contributes to the skeletal pathology in Alpl(-/-) mice, was present in the generally unmineralized Alpl(-/-) mantle dentin at ruptured mineralizing matrix vesicles, as detected by immunohistochemistry and by immunogold labeling. However, ablating the OPN-encoding Spp1 gene in Alpl(-/-) mice was insufficient to rescue the dentin mineralization defect. Administration of bioengineered mineral-targeting human TNAP (ENB-0040) to Alpl(-/-) mice corrected defective dentin mineralization in the molar roots. These studies reveal that TNAP participates in root dentin formation and confirm that reduction of PP(i) during dentinogenesis is necessary for odontoblast differentiation, dentin matrix secretion, and mineralization. Furthermore, these results elucidate developmental mechanisms underlying dentin pathology in HPP patients, and begin to explain the reported variability in the dentin/pulp complex pathology in these patients.
组织非特异性碱性磷酸酶(TNAP)在矿化组织中表达,其功能是降低焦磷酸(PP(i)),焦磷酸是一种强烈的矿化抑制剂。TNAP 功能丧失会导致低磷酸酶血症(HPP),这是一种遗传性疾病,其特征是 PP(i)增加,导致佝偻病和骨软化症。HPP 患者和 Alpl(-/-)小鼠(婴儿型 HPP 的模型)的牙骨质根缺陷都有很好的描述。在 Alpl(-/-)小鼠中,根中的牙本质矿化特别延迟;然而,来自 HPP 患者的报告在牙本质缺陷方面是可变和不一致的。在本研究中,我们旨在确定 Alpl(-/-)小鼠观察到的牙本质发生变化的分子基础。TNAP 被发现由成熟的成牙本质细胞高度表达,并且 Alpl(-/-)磨牙和切牙根表现出牙本质矿化缺陷,从轻度延迟到严重干扰根牙本质发生。缺乏罩牙本质矿化与排列紊乱和形态异常的成牙本质细胞有关,这些细胞的标记基因骨钙素和牙本质涎磷蛋白表达受到破坏。在 Alpl(-/-)牙本质基质中,基质小泡的形成、矿化起始和破裂没有受到影响。骨桥蛋白(OPN)是一种矿化抑制剂,它导致 Alpl(-/-)小鼠的骨骼病理学,通过免疫组织化学和免疫金标记,在通常未矿化的 Alpl(-/-)罩牙本质基质中的破裂矿化基质小泡中检测到 OPN 的存在。然而,在 Alpl(-/-)小鼠中敲除编码 OPN 的 Spp1 基因不足以挽救牙本质矿化缺陷。向 Alpl(-/-)小鼠施用生物工程矿化靶向人 TNAP(ENB-0040)可纠正磨牙根中的牙本质矿化缺陷。这些研究表明 TNAP 参与根牙本质的形成,并证实牙本质发生过程中 PP(i)的减少对于成牙本质细胞分化、牙本质基质分泌和矿化是必要的。此外,这些结果阐明了 HPP 患者牙本质病理学的发育机制,并开始解释这些患者牙本质/牙髓复合体病理学的报告变异性。